Shetzline M - Search Results

1

A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator.

Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, Leserman J, Shetzline M, Dalton C, Bangdiwala SI. Drossman DA, et al. Among authors: shetzline m. Gastroenterology. 2005 Mar;128(3):580-9. doi: 10.1053/j.gastro.2004.12.006. Gastroenterology. 2005. PMID: 15765393

2

Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.

Tillisch K, Labus JS, Naliboff BD, Bolus R, Shetzline M, Mayer EA, Chang L. Tillisch K, et al. Among authors: shetzline m. Am J Gastroenterol. 2005 Apr;100(4):896-904. doi: 10.1111/j.1572-0241.2005.41211.x. Am J Gastroenterol. 2005. PMID: 15784038

3

Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.

Chey WD, Paré P, Viegas A, Ligozio G, Shetzline MA. Chey WD, et al. Among authors: shetzline ma. Am J Gastroenterol. 2008 May;103(5):1217-25. doi: 10.1111/j.1572-0241.2008.01808.x. Am J Gastroenterol. 2008. PMID: 18477346 Free article. Clinical Trial.

4

Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function.

Crowell MD, Shetzline MA, Moses PL, Mawe GM, Talley NJ. Crowell MD, et al. Among authors: shetzline ma. Curr Opin Investig Drugs. 2004 Jan;5(1):55-60. Curr Opin Investig Drugs. 2004. PMID: 14983974 Review.

5

Patients with irritable bowel syndrome or constipation have an increased risk for ischaemic colitis.

Suh DC, Kahler KH, Choi IS, Shin H, Kralstein J, Shetzline M. Suh DC, et al. Among authors: shetzline m. Aliment Pharmacol Ther. 2007 Mar 15;25(6):681-92. doi: 10.1111/j.1365-2036.2007.03250.x. Aliment Pharmacol Ther. 2007. PMID: 17311601 Free article.

6

Safety, tolerability, and efficacy of tegaserod over 13 months in patients with chronic constipation.

Müller-Lissner S, Kamm MA, Musoglu A, Earnest DL, Dunger-Baldauf C, Shetzline MA. Müller-Lissner S, et al. Among authors: shetzline ma. Am J Gastroenterol. 2006 Nov;101(11):2558-69; quiz 2671. doi: 10.1111/j.1572-0241.2006.00789.x. Am J Gastroenterol. 2006. PMID: 17090282 Clinical Trial.

7

Ischemic colitis, irritable bowel syndrome, and tegaserod--an alternative viewpoint.

Shetzline MA, Cohard-Radice M, Joelsson B. Shetzline MA, et al. Pharmacotherapy. 2005 Nov;25(11):1684-5; discussion 1685. doi: 10.1592/phco.2005.25.11.1684. Pharmacotherapy. 2005. PMID: 16232032 No abstract available.

8

Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity.

Rodriguez-Stanley S, Zubaidi S, Proskin HM, Kralstein JR, Shetzline MA, Miner PB Jr. Rodriguez-Stanley S, et al. Among authors: shetzline ma. Clin Gastroenterol Hepatol. 2006 Apr;4(4):442-50. doi: 10.1016/j.cgh.2006.01.014. Clin Gastroenterol Hepatol. 2006. PMID: 16616348 Clinical Trial.

9

Re: Percutaneous endoscopic gastrostomy.

Shetzline MA. Shetzline MA. Am J Gastroenterol. 2001 May;96(5):1666-7. doi: 10.1111/j.1572-0241.2001.03838.x. Am J Gastroenterol. 2001. PMID: 11374739 No abstract available.

10

Factors motivating dyspepsia patients to enter clinical research.

Rojavin MA, Downs P, Shetzline MA, Chilingerian R, Cohard-Radice M. Rojavin MA, et al. Among authors: shetzline ma. Contemp Clin Trials. 2006 Apr;27(2):103-11. doi: 10.1016/j.cct.2005.11.014. Epub 2006 Jan 18. Contemp Clin Trials. 2006. PMID: 16413229

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page